Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix

Imaging for Amyloid Deposits Also Shows Promise for Detecting Cardiac Amyloidosis

By Medimaging International staff writers
Posted on 21 Feb 2013
Print article
Whereas amyloid imaging may now be most associated with detecting plaques in the brain, it also has the potential to alter the way cardiac amyloidosis is diagnosed. According to first-of-its-kind research, positron emission tomography (PET) with 11C-PIB (Pittsburgh compound B) can effectively visualize amyloid deposits in the heart. Currently, there is no other noninvasive test available for specific diagnosis.

The study’s findings were published in the February 2013 issue of the Journal of Nuclear Medicine. Cardiac amyloidosis is a deadly disorder caused by abnormal amyloid deposits in the heart tissue. Early diagnosis before structural change to the heart tissue has occurred is important for disease prognosis and for treatment monitoring. Echocardiography is the current mainstay of imaging in cardiac amyloidosis; a cardiac biopsy is used to validate diagnosis.

“Imaging with 11C-PIB provides a noninvasive and specific means of showing distribution of amyloid in an organ. This gives a unique opportunity to follow and monitor therapy, as amyloid deposits in the heart should decrease with successful therapy,” said Gunnar Antoni, PhD, from department of medicinal chemistry, Uppsala University (Sweden), and lead author of the research.

The study included 10 patients diagnosed with cardiac amyloidosis and five healthy individuals. PET/computed tomography (CT) with 11C-PIB was used to visualize amyloid deposits in the heart and with 11C-acetate to measure myocardial blood flow.

Uptake of 11C-PIB was measured 15–25 minutes after injection. Obvious uptake of 11C-PIB was noted in the left ventricle wall of all patients with cardiac amyloidosis, while no uptake was seen in the healthy volunteers. In half of the patients, 11C-PIB was also detected in the right ventricle wall, and nine of the patients had signs of reversible uptake, with a maximum concentration at 10–15 minutes after injection. Myocardial blood flow was significantly lower in patients with cardiac amyloidosis; however, no significant correlation between myocardial blood flow and 11C-PIB uptake was found.

“This study emphasizes the strength of molecular imaging for detecting an underlying and significant molecular aberration in a disease that presents with unspecific symptoms and signs,” noted Dr. Antoni. “The potential for molecular imaging to provide valuable information for other diseases is of great value to the field of medicine.”

Related Links:
Uppsala University






Print article
Radcal

Channels

Radiography

view channel
Image: The CAD platform is available on the Aspire Cristalle digital mammography system (Photo courtesy of Fujifilm).

CAD Solution Available on New Digital Mammography System

An industry-leading provider of cancer detection, radiation therapy, and workflow solutions, has announced that the company's mammography CAD solution is now available on a new advanced Full Field Digital... Read more

Ultrasound

view channel
Image: The SonoSite SII portable, mountable ultrasound system (Photo courtesy of Fujifilm SonoSite).

Mountable Ultrasound System Empowers Clinical Efficiency

A new ultrasound system developed for regional anesthesia, vascular access, and trauma applications provides a smart user interface that adapts to the user’s imaging needs. The SonoSite SII is a portable,... Read more

General/Advanced Imaging

view channel

Early Intervention with Stent Retrievers Improves Outcomes for Ischemic Stroke Patients

New research has shown that restoration of blood flow to the brain within two and a half hours from the onset of the first signs of acute ischemic stroke resulted in none, or only minimal disability in 91% of patients. Endovascular therapy in the early stages of the onset of stroke symptoms significantly improved functional... Read more

Imaging IT

view channel

World Medical VR Technology Company Unveils First-of-Its-Kind Neurosurgery Surgical Visualization Platform

A novel neurosurgery Virtual Reality (VR) visualization platform has been demonstrated at the NVIDIA GPU Technology Conference (GTC) 2016 in California (USA). The enterprise-wide solution is intended to help clinicians plan, prepare, and perform neurosurgery, and enable the surgeon to empower and engage their patients... Read more

Industry News

view channel
Image: Mazor Robotics\' Renaissance Image Guidance Robot in the Hand of a Surgeon (Photo courtesy of Mazor Robotics).

Medical Image Guidance Systems Developer Reports Demand for Systems in Q1 2016

The developer of an innovative guidance system that can improve the accuracy and clinical outcomes for spine and brain surgery procedures, has announced demand for its systems during the first quarter of 2016.... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.